CGIM
IDXX icon

Capital Group Investment Management’s Idexx Laboratories IDXX Stock Holding History

Capital Group Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,848
Closed -$2.69M – 190
2023
Q4 		$2.69M Hold
4,848
– – 0.28% 104
2023
Q3 		$2.12M Hold
4,848
– – 0.14% 117
2023
Q2 		$2.43M Buy
4,848
+82
+2% +$39.3K 0.12% 114
2023
Q1 		$2.38M Sell
4,766
-664
-12% -$318K 0.13% 116
2022
Q4 		$2.22M Buy
+5,430
New +$2.11M 0.09% 123

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Group Investment Management's IDXX Position: Q1 2024 in Review

Capital Group Investment Management sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 4,848 shares — an estimated $2.69M sold.

Capital Group Investment Management first reported a position in IDXX in Q4 2022 and held it in 5 quarters. The position peaked at $2.69M in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Capital Group Investment Management reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • Capital Group Investment Management sold 4,848 Idexx Laboratories shares in Q1 2024, an estimated $2.69M.
  • Capital Group Investment Management first reported a position in Idexx Laboratories in Q4 2022 and held it in 5 quarters.
  • Capital Group Investment Management's Idexx Laboratories position peaked at $2.69M in Q4 2023.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Capital Group Investment Management's 13F filing for Q1 2024, filed 14 May 2024.